Inhibition of plasminogen activator inhibitor-1 by 11-Keto-9(E),12(E)-octadecadienoic acid, a novel fatty acid produced by Trichoderma sp.

Journal of Antibiotics

Volumn 52, Issue 9, 1999, Pages 797-802

  Chikanishi, Toshihiro ^a   Shinohara, Chikara ^a   Kikuchi, Tadashi ^a   Endo, Akira ^a   Hasumi, Keiji ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID DERIVATIVE; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID DERIVATIVE; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; STEARIC ACID; UROKINASE;

ANIMAL CELL; ARTICLE; CATTLE; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; TRICHODERMA; VASCULAR ENDOTHELIUM;

TRICHODERMA VIRIDE;

EID: 0032827853     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.797     Document Type: Article

References (18)

1. AZNAR, J. & A. ESTELLES: Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery diseases. Haemostasis 24: 243-251, 1994
2. WIMAN, B.: Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb. Haemost. 74: 71-76, 1995
3. VAN MEIJER, M. & H. PANNEKOEK: Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 9: 263-276, 1995
4. NY, T.; M. SAWDEY, D. LAWRENCE, J. L. MILLAN & D. J. LOSKUTOFF: Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA 83: 6776-6780, 1986
5. LINDAHL, T. L.; O. Sigurdardottir & B. Wiman: Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb. Haemost. 62: 748-751, 1989
6. HEKMAN, C. M. & D. J. LOSKUTOFF: Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J. Biol. Chem. 260: 11581-11587, 1985
7. LAWRENCE, D. A.; S. T. OLSON, S. PALANIAPPAN & D. GINSBURG: Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem. 269: 27657-27662, 1994
8. SHINOHARA, C.; K. Hasumi, T. Chikanishi, T. Kikuchi & A. Endo: 11-Keto-9(E), 12(E)-octadecadienoic acid, a novel fatty acid that enhances fibrinolytic activity of endothelial cells. J. Antibiotics 52: 171-174, 1999
9. LAWRENCE, D.; L. STRANDBERG, T. GRUNDSTRÖM & T. NY: Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and reeombinant forms purified from eucaryotic cells. Eur. J. Biochem. 186: 523-533, 1989
10. STOPPELLI, M. P.; C. TACCHETTI, M. V CUBELLIS, A. CORTI, V J. HEARING, G. CASSANI, E. APPELLA & F. BLASI: Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 45: 675-684, 1986
11. LOSKUTOFF, D. J. & R. SCHLEEF: Plasminogen activators and their inhibitors. Methods Enzymol. 163: 293-302, 1988
12. MISKIN, R. & R. ABRAMOVITZ: One-phase reverse zymography after denaturing gel electrophoresis: high sensitivity detection of activity of plasminogen activator inhibitor 2 and other protease inhibitors. Fibrinolysis 9: 331-342, 1995
13. UCHIDA, K.; S. TOYOKUNI, K. NISHIKAWA, S. KAWAKISHI, H. ODA, H. HIAI & E. R. STADTMAN: Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33: 12487-12494, 1994
14. REQUENA, J. R.; M. X. Fu, M. U. AHMED, A. J. JENKINS, T.J. LYONS, J.W. BAYNES & S.R. THORPE: Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322: 317-325, 1997
15. KEIJER, B. J.; M. LINDERS, A.-J. VAN ZONNEVELD, H. J. EHRLICH, J.-P. DE BOER & H. PANNEKOEK: The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance. Blood 78: 401-409, 1991
16. BRYANS, J.; P. CHARLTON, I. CHICARELLI-ROBINSON, M. COLLINS, R. FAINT, C. LATHAM, I. SHAW & S. TREW: Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp. J. Antibiotics 49: 1014-1021, 1996
17. CHARLTON, P. A.; R. W. FAINT, F. BENT, J. BRYANS, I. CHICARELLI-ROBINSON, I. MACKIE, S. MACHIN & P. BEVAN: Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb. Haemost. 75: 808-815, 1996
18. FRIEDERICH, P. W.; M. LEVI, B. J. BIEMOND, P. CHARLTON, D. TEMPLETON, A. J. VAN ZONNEVELD, P. BEVAN, H. PANNEKOEK & J. W. TEN KATE: Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and produces postthrombolysis thrombus growth in rabbits. Circulation 96: 916-921, 1997